[Pharmacological and non-pharmacological treatment of Alzheimer's dementia].
BDH-Klinik Elzach. claus.wallesch@neuroklinik-elzach.de
Claus-W
CW
Wallesch
D000544:Alzheimer Disease / Q000175:diagnosis / Q000628:therapy*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D008559:Memantine / Q000009:adverse effects / Q000627:therapeutic use; D001523:Mental Disorders / Q000175:diagnosis / Q000628:therapy; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012955:Societies, Medical
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D008559:Memantine